Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

What is your preferred treatment choice for GBM that crosses the corpus callosum?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Cleveland Clinic

We never push for aggressive surgery in this case. The surgeons will not resect disease from the corpus callosum (due to resulting neurological issues), so further attempt of surgery would delay therapy in a group of patients that tend to do poorly, despite favorable prognostic factors.

Do you make any distinction or have any special consideration when considering a patient for hypofractionation for left versus right breast cancer?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Rutgers Robert Wood Johnson Medical School

In general I see no major issue with hypofractionation and cardiac issues. Whether standard or hypofractionation the cardiac dose should be minimized to the greatest extent possible by any combination of techniques including deep breath holding, cardiac blocks, etc. Keeping the mean heart dose as lo...

Is it possible to palliate presacral recurrences of rectal cancer in patients who previously received neoadjuvant chemoradiation to the rectum?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Our institution has reported on a small series of presacral recurrences in previously treated patients with SBRT with good response and palliation.http://www.ncbi.nlm.nih.gov/pubmed/22269400

In post-op RT for head and neck cancer with a close or positive margin, is there data suggesting that 66 Gy at 2 Gy per fraction provides better local control than 63 Gy at 1.8 Gy per fraction?

3
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Texas MD Anderson Cancer Center

I do not think there is any good data to support this. Historically, 2 randomized trials come to mind. The first is the MDA Peters et al trial, that looked at varying doses with 1.8 gy fractions, and concluded that 63Gy was the optimal dose for higher risk patients. The second study was published by...

Would you treat the inguinal nodes in a patient who had an adenocarcinoma excised from the anal canal?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Washington University School of Medicine

I would definitely include the external iliac nodes for such a case. I would also definitely add the inguinal nodes if the cancer were extending to the verge or beyond. I would also scrutinize the imaging studies very carefully; a 1-2 cm inguinal node has to be of greater concern in this setting tha...

Are there situations where you would use hypofractionated radiotherapy for Stage III breast cancer?

8
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Utah

The answer to this question is complex, and cannot be adequately explained in a brief response.Treatment of local advanced breast with hypofractionated radiation is not currently an accepted standard practice in this country. This situation occurs in both breast conservation and mastectomy (+/- reco...

When treating rectal cancer with neoadjuvant chemoRT, is it appropriate to employ IMRT planning, rather than 3D conformal, for all cases, or should IMRT be reserved for special circumstances?

6
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan-Kettering Cancer Center

Special circumstances. When considering the use of IMRT for any disease site, one should always have evidence to support it over 3D CRT or at least a good rationale if there is a gap in the evidence. For rectal cancer, there is not much evidence that IMRT reduces acute GI toxicity. The RTOG 0247 was...

Do you treat rectosigmoid/upper rectal cancers with neoadjuvant chemoradiation?

15
5 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Vermont Cancer Center

The 12-year update to the phase III pre-op RT Dutch rectal trial found a local control benefit with RT regardless of location (VanGijn et al., Lancet Oncol. 2011; 12(6):575-82.). In the Dutch update, tumor location was analyzed as a continuous variable. This is different from the every 5 cm cut-offs...

What dose and expansion of GTV is recommended for a low grade glioma?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Quint Cities Radiation Oncology

I think doses between 45-54 Gy are probably reasonable for low grade gliomas when electing to treat with RT. Several studies have not shown a benefit with dose escalation in the treatment of low grade gliomas (EORTC 45 Gy vs 59.4 Gy; Intergroup 50.4 Gy vs 64.8 Gy). In terms of treatment volumes, RTO...

What is the ideal time interval to wait before starting radiation for postoperative treatment of benign brain lesions?

1
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · GammaWest Cancer Services

The answer to this question may vary by tumor type and expected tumor growth rate, but since meningioma was first among the cited examples, permit a brief comment with that in mind. For meningioma, likely quite similar to acoustic neuroma, pituitary ademona and other typically slowly progressive CNS...